| Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|
 Filter
|
Homo sapiens
|
Yuxuan Sun
|
||||||
| GSE241934 |
Neoadjuvant sintilimab plus chemotherapy in early-stage EGFR-mutant NSCLC: phase 2 trial interim results (NEOTIDE/CTONG2104)
|
|
88 | Yuxuan Sun | May 17, 2024 |
